The disclosed wearable device modulates a patient's gastric emptying time and/or gastric retention time. The wearable device includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 dermatome to a T12 dermatome or meridian of the patient, a C5 to a T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.

A catheter including an elongated tube having a channel; an inflatable chamber coupled to the elongated tube and in fluid communication with the channel; and a high-density liquid delivery system in fluid communication with the channel, the high-density liquid delivery system delivering a high-density liquid to the inflatable chamber via the channel to cause the inflatable chamber to expand.

A micro impulse radar (MIR) system includes a first sensor, a second sensor, and a control circuit. The first sensor includes a micro impulse radar (MIR) sensor configured to receive a plurality of radar returns corresponding to an MIR radar signal transmitted towards a subject. The second sensor is configured to detect sensor data regarding the subject. The control circuit is configured to calculate a physiological parameter of the subject based on the plurality of radar returns and the sensor data.

A stethoscope system includes a microphone device configured to receive a plurality of sound waves from the subject and output an audio signal corresponding to the plurality of sound waves; and a control circuit configured to receive the audio signal from the microphone device and calculate a physiological parameter based on the audio signal.

A system for monitoring autoregulation may include processing circuitry configured to receive a blood pressure signal indicative of an acquisition blood pressure of a patient at an acquisition site and an oxygen saturation signal indicative of an oxygen saturation of the patient. The processing circuitry may determine a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal. The processing circuitry may determine a non-cerebral autoregulation status value based on the cerebral autoregulation status value and an adjustment value. The processing circuitry provide to an output device a signal indicative of the non-cerebral autoregulation status value and a signal indicative of the cerebral autoregulation status value to enable a clinician to monitor the autoregulation status of the patient.

A non-invasive system for sampling gastrointestinal microbiota with their associated environment for discovery, characterization, medical research, diagnostics, and treatment using an ingestible, non-digestible sampling capsule. The capsule device, with ports open for acquiring a sample of gastrointestinal microbiota and content, is placed inside an immediate or delayed release capsule. When the outer capsule dissolves according to its specifications, enteric fluid and content enters the sampling capsule through the ports triggering a hydrophilic stop to release a pulling force to close the ports by enveloping the capsule outer casing over the inner casing, capturing the sample, and holding it sealed until it completes passage through the digestive track, and is recovered from feces for analysis.

A health diagnostics system includes an interne-of-things (IoT) toilet device adapted to be mounted on or within a toilet bowl. The IoT toilet device comprises one or more sensors for collecting measurements of human excrement residing within the toilet bowl and also includes an excrement analysis module stored in memory and executable by a processor to infer a property of a human bowel movement based on the collected measurements, where the inferred property includes at least one of color, volume, mass, consistency, and frequency

A pressure measuring system, including a tube system having at least one first device for measuring pressure in a fluid. The at least one first device includes a coupling element, at least one pressure transducer and at least one measuring chamber, which can be filled with a fluid. Between the first device and the feed of the fluid, the tube system has a second device for regulating a fluid flow, the second device having a tube section through which fluid can flow and at least one tube clamp, which can be set in the regulation positions open, closed and perfused.

A wearable sensor belt used as a reference frame for determining a location of an in-vivo device in the gastrointestinal (GI) tract, the belt including N magnetic field generating coils and M magnetic field sensors configured for dynamic calibration of the belt's geometry in order to accommodate for dynamic changes in the shape and/or size of the belt from one subject to another, and for dynamic changes in the shape and/or size of the belt as a result of changes in a subject's posture. A method for localizing an in-vivo device swallowed by a subject using a sensor belt is also described.

Sampling systems that include an absorbent material a preservative, such as an analyte preservative, as well as related materials and methods, are disclosed.